The Latin America, Middle East and Africa Opioids Market is expected to witness market growth of 6.3% CAGR during the forecast period (2021 2027).
A depressed state that persist for at least two years is known as persistent depressive disorder (also known as dysthymia). A person with persistent depressive disorder may experience episodes of major depression as well as periods of less severe symptoms, but the symptoms must remain for at least two years in order to be labelled with persistent depressive disorder. The number of people being diagnosed with depression is growing at an accelerating rate every year. The causes of depression are thought to be ranging from genetic and biochemical to environmental and psychological factors according to many researches.
Depression can strike at any age, but it is more common in adults. Depression is now recognized as a condition that affects children and adolescents, albeit it is sometimes accompanied with irritation rather than a poor mood. The root of various chronic mood and anxiety problems in adults lies in their anxiety riddled childhood. Opioid medication is started slightly more frequently in depressed individuals than in non-depressed patients
The United Arab Emirates (UAE) has one of the fastest-growing economies in the world, which has resulted in an increase in noncommunicable diseases such as cancer. Despite screening and early detection efforts that appear to be far from goal coverage of the intended population, the number of reported cases and death have been rising in the UAE over the years. The NCBI (National Center for Biotechnology Information) presented essential aspects of a proposed national cancer control plan for the UAE in one paper. The idea is still in the works and has yet to be formally adopted. Accurate data, a reliable cancer registry, and periodic monitoring and review are all required for a comprehensive and effective management plan. The UAE's cancer management plan is being developed in accordance with WHO and EMRO guidelines, with specific aims and targets in mind. The goals are to fight cancer, limit its occurrence, control mortality, and enhance cancer patients' outcomes and quality of life. Improved public health education, prevention, early detection, fast diagnosis, treatment facilitation, continuity of care, performance evaluation, workforce training, and research are also priorities.
The Brazil market dominated the LAMEA Opioids Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $89.4 million by 2027. The Argentina market is estimated to grow at a CAGR of 6.9% during (2021 - 2027). Additionally, The UAE market is expected to display a CAGR of 6% during (2021 - 2027).
Based on Application, the market is segmented into Pain Management, Cough Treatment and Diarrhea Treatment. Based on Product Type, the market is segmented into Methadone, Oxycodone, Hydrocodone, Fentanyl, Codeine, Morphine and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Endo International PLC, Mallinckrodt PLC, Sanofi S.A., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., and Purdue Pharma L.P.
A depressed state that persist for at least two years is known as persistent depressive disorder (also known as dysthymia). A person with persistent depressive disorder may experience episodes of major depression as well as periods of less severe symptoms, but the symptoms must remain for at least two years in order to be labelled with persistent depressive disorder. The number of people being diagnosed with depression is growing at an accelerating rate every year. The causes of depression are thought to be ranging from genetic and biochemical to environmental and psychological factors according to many researches.
Depression can strike at any age, but it is more common in adults. Depression is now recognized as a condition that affects children and adolescents, albeit it is sometimes accompanied with irritation rather than a poor mood. The root of various chronic mood and anxiety problems in adults lies in their anxiety riddled childhood. Opioid medication is started slightly more frequently in depressed individuals than in non-depressed patients
The United Arab Emirates (UAE) has one of the fastest-growing economies in the world, which has resulted in an increase in noncommunicable diseases such as cancer. Despite screening and early detection efforts that appear to be far from goal coverage of the intended population, the number of reported cases and death have been rising in the UAE over the years. The NCBI (National Center for Biotechnology Information) presented essential aspects of a proposed national cancer control plan for the UAE in one paper. The idea is still in the works and has yet to be formally adopted. Accurate data, a reliable cancer registry, and periodic monitoring and review are all required for a comprehensive and effective management plan. The UAE's cancer management plan is being developed in accordance with WHO and EMRO guidelines, with specific aims and targets in mind. The goals are to fight cancer, limit its occurrence, control mortality, and enhance cancer patients' outcomes and quality of life. Improved public health education, prevention, early detection, fast diagnosis, treatment facilitation, continuity of care, performance evaluation, workforce training, and research are also priorities.
The Brazil market dominated the LAMEA Opioids Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $89.4 million by 2027. The Argentina market is estimated to grow at a CAGR of 6.9% during (2021 - 2027). Additionally, The UAE market is expected to display a CAGR of 6% during (2021 - 2027).
Based on Application, the market is segmented into Pain Management, Cough Treatment and Diarrhea Treatment. Based on Product Type, the market is segmented into Methadone, Oxycodone, Hydrocodone, Fentanyl, Codeine, Morphine and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Endo International PLC, Mallinckrodt PLC, Sanofi S.A., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., and Purdue Pharma L.P.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Pain Management
- Cough Treatment and
- Diarrhea Treatment
By Product Type
- Methadone
- Oxycodone
- Hydrocodone
- Fentanyl
- Codeine
- Morphine and
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Endo International PLC
- Mallinckrodt PLC
- Sanofi S.A.
- Pfizer, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Purdue Pharma L.P.
Unique Offerings from the publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Opioids Market by Application
Chapter 4. LAMEA Opioids Market by Product Type
Chapter 5. LAMEA Opioids Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- Johnson & Johnson
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Endo International PLC
- Mallinckrodt PLC
- Sanofi S.A.
- Pfizer, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Purdue Pharma L.P.
Methodology
LOADING...
